Evotec Q4 2025 slides: strong finish masks segment headwinds
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Iran latest: Hegseth declares U.S. victory in Iran amid ceasefire agreement These AI-picked stocks are SKYROCKETING on Iran ceasefire deal - See them here Oil prices tumble as Trump touts Iran ceasefire, vows help with Hormuz traffic Gold prices jump after Trump announces Iran ceasefire (South Africa Philippines Nigeria) Evotec Q4 2025 slides: strong finish masks segment headwinds By Company News Published 04/08/2026, 09:46 AM Evotec Q4 2025 slides: strong finish masks segment headwinds 0 EVO 6.98% Introduction & Market Context Evotec SE ADR (NYSE:EVO) presented its fourth quarter and full-year 2025 results on April 8, 2026, revealing a strong quarterly finish that propelled shares 9.3% higher to $2.82 in premarket trading. The German drug discovery and development company delivered financial results at the high end of guidance while unveiling a comprehensive transformation plan designed to address underlying business challenges and establish a pathway to sustainable profitability. The presentation highlighted a tale of two business segments: Just-Evotec Biologics experiencing breakthrough growth driven by a landmark $650 million Sandoz transaction, while the Discovery & Preclinical Development (D&PD) segment faced continued market headwinds. CEO Christian Wojczewski and CFO Paul Hitchin outlined the company’s "Horizon" transformation initiative, targeting approximately €75 million in annual cost savings by the end of 2027 through site consolidations and workforce reductions. Quarterly Performance Highlights Evotec’s fourth quarter performance demonstrated significant momentum, with revenues reaching €253.3 million, representing a 14.5% year-over-year increase from €221.2 million in Q4 2024. More impressively, adjusted Group EBITDA more than doubled to €58.0 million from €28.5 million in the prior-year quarter, reflecting improved operational efficiency and favorable business mix. As shown in the following co...
Read full article at source